Background Two previous national epidemiological studies, IBERPOC in 1997 and EPISCAN in 2007, determined the COPD burden in Spain. Changes in demographics and …
DP Tashkin, ME Wechsler - International journal of chronic …, 2018 - Taylor & Francis
COPD is a significant cause of morbidity and mortality. In some patients with COPD, eosinophils contribute to inflammation that promotes airway obstruction; approximately a …
MG Matera, CP Page, L Calzetta, P Rogliani… - Pharmacological …, 2020 - Elsevier
Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …
MA Martinez-Garcia, R Faner, G Oscullo… - American journal of …, 2020 - atsjournals.org
Rationale: Treatment of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroids (ICS) is controversial, because it can reduce the risk of future exacerbations …
M Torres-Durán, JL Lopez-Campos… - Orphanet journal of rare …, 2018 - Springer
Background Alpha-1 antitrypsin deficiency (AATD) is a rare hereditary condition that leads to decreased circulating alpha-1 antitrypsin (AAT) levels, significantly increasing the risk of …
D Jiménez, A Agustí, E Tabernero, L Jara-Palomares… - Jama, 2021 - jamanetwork.com
Importance Active search for pulmonary embolism (PE) may improve outcomes in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD). Objective …
JL López-Campos… - Archivos de …, 2020 - pubmed.ncbi.nlm.nih.gov
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges Global Strategy for the Diagnosis, Management, and …
VK Sidhaye, K Nishida… - European Respiratory …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide in 2015. Current treatments for patients ease discomfort and help decrease …